SiriusPoint Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPNT research report →
Range $30 – $31
Price Chart
About the company
SiriusPoint Ltd. provides multi-line reinsurance and insurance products and services worldwide. It operates in four segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty.
- CEO
- Scott Egan
- IPO
- 2013
- Employees
- 1,068
- HQ
- Pembroke, PE, BM
Get TickerSpark's AI analysis on SPNT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.04B
- P/E
- 6.31
- Fwd P/E
- 9.34
- PEG
- 0.04
- P/S
- 0.90
- P/B
- 1.36
- EV/EBITDA
- 4.68
- Div Yield
- 0.00%
- Gross Margin
- 54.93%
- Op Margin
- 18.04%
- Net Margin
- 14.93%
- ROE
- 21.64%
- ROIC
- -117.37%
Latest fiscal year · YoY change
- Revenue
- $3.21B+22.6%
- Gross Profit
- $1.69B+131.4%
- Op Income
- $541.30M
- Net Income
- $459.60M+129.9%
- EPS
- $3.81+259.4%
- OCF Growth
- +37.1%
- FCF Growth
- +37.1%
- 52W High
- $27.55
- 52W Low
- $19.15
- 50D MA
- $25.44
- 200D MA
- $23.47
- Beta
- 0.57
- RSI (14)
- 54
- Avg Volume
- 930.25K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
SiriusPoint posted another strong quarter with 20% insurance-and-services growth, a 90.1% core combined ratio, and announced a loss portfolio transfer to largely eliminate runoff volatility.· November 6, 2026
- Core gross written premium rose 14% to $991 million, with insurance and services up 20% and reinsurance up 3% in the quarter.
- Core combined ratio was 90.1%; underwriting income was $76 million, operating net income was $103 million, and operating EPS was $0.88, up 19% year over year.
- Diluted book value per share excluding AOCI increased by $0.73 to $20.21 in the quarter and was up 12% year to date.
- Management announced a loss portfolio transfer with Riverstone that should reduce runoff exposures to de minimis levels, free up over $200 million of capital, and lift BSCR by around 20 points.
- Capital returns continue: SiriusPoint repurchased $27 million of shares in the quarter, with $74 million remaining under authorization and plans to resume buybacks.
Third-quarter core gross written premium increased 14% to $991 million, net written premium increased 2%, earned premiums increased 19%, and the core combined ratio was 90.1%. Underwriting income was $76 million, net services fee income was $12 million, total investment income was $69 million, operating net income was $103 million, and operating earnings per diluted share were $0.88, up 19% year over year. Diluted book value per share excluding AOCI increased by $0.73 to $20.21 in the quarter. For the first 9 months, core gross written premium grew 7% to nearly $3 billion, core underwriting income rose 22% to $202 million, the core combined ratio improved to 90.1%, operating EPS increased 17% to $2.29, and diluted book value per share excluding AOCI increased by $2.11 to $20.21. Management did not provide formal next-quarter or full-year financial guidance, but said A&H premiums should return to low single-digit growth in Q4, specialty P&C premiums are expected to be modestly lower year over year in Q4 due to a FinPro nonrenewal and comparison effects, and growth is expected to resume in 2027 as comparisons normalize.
Scott Egan emphasized that SiriusPoint is now behaving more like a specialty underwriter than a traditional Bermuda reinsurer, with disciplined growth, low volatility, and returns above its 12% to 15% ROE target range. He framed the Riverstone LPT as the completion of the legacy runoff cleanup, saying it closes the chapter on pre-2023 business and lets the company focus capital on future growth and shareholder returns. His tone was confident and upbeat, with repeated emphasis on underwriting discipline, portfolio flexibility, and the strength of the balance sheet.
Jim McKinney focused on the underlying financial momentum: core gross written premium of $991 million, underwriting income of $76 million, operating net income of $103 million, and operating EPS of $0.88. He highlighted the 90.1% core combined ratio, $198 million of net investment income for the first 9 months, $1 billion of liquidity, a 232% estimated BSCR ratio, and a 23% debt-to-capital ratio. On the LPT, he said the day-1 cost is approximately $60 million, the capital uplift is about 20 BSCR points on a pro forma basis, and the company plans to resume repurchases while continuing to prioritize profitable growth.
Analysts focused on the A&H slowdown tied to an international A&H relationship exit, the economics and timing of the LPT, the possibility of further balance sheet optimization, the recast segment structure, and the sustainability of favorable prior-year development. Management said the A&H exit was driven by performance and that the segment still performed strongly overall, while the LPT should amortize over roughly 2.5 to 3 years and carry about $15 million to $16 million of annual claims administration costs. They also said there is still some further debt-stack optimization possible over time, but nothing major remains, and they reiterated that the recast better reflects the company’s specialty-insurer identity and how it manages the business.
The call supports a bull case built on sustained underwriting profitability, with a 90.1% combined ratio and returns above target even before the legacy runoff is removed. Management also pointed to a healthy pipeline, strong capital flexibility, and the possibility that the LPT reduces volatility and aligns reported earnings more closely with the core business.
The main risks discussed were softer pricing and more competitive market conditions in several lines, especially reinsurance and property cat, plus the possibility that Q4 specialty P&C premiums come in modestly lower year over year because of a FinPro nonrenewal and comparison effects. The LPT also comes with a roughly $60 million day-1 cost and leaves claims administration work for about 2.5 to 3 years, so legacy-related expenses do not disappear immediately.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 87.6%
- Shares Outstanding
- 115.03M
- Float Shares
- 100.72M
of shares held by institutions
255 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 12.13M | ▲ 368.91K |
| Blackrock, Inc. | 11.43M | ▲ 98.54K |
| Dimensional Fund Advisors LP | 7.62M | ▲ 309.10K |
| Wellington Management Group Llp | 6.44M | ▲ 3.10M |
| Vanguard Portfolio Management LLC | 6.11M | ▼ 477.06K |
| American Century Companies Inc | 5.20M | ▼ 372.58K |
| State Street Corp | 4.85M | ▼ 15.80K |
| Vanguard Capital Management LLC | 4.73M | ▼ 13.61K |
| Price T Rowe Associates Inc | 3.95M | ▲ 1.04M |
| Capital World Investors | 3.60M | 0 |
| Donald Smith & Co., Inc. | 3.34M | ▼ 2.83M |
| Victory Capital Management Inc | 3.03M | ▼ 497.45K |
Held by 409 ETFs
Biggest fund positions in SPNT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 31, 26 | Leonardo Thomas C. | other | 1,702 |
| May 31, 26 | McKinney James J. | other | 3,648 |
| May 29, 26 | Robart Jason | other | 5,903 |
| May 29, 26 | Mahmud Mehdi | other | 5,903 |
| May 29, 26 | Masojada Bronislaw Edmund | other | 5,903 |
| May 29, 26 | Ludlow Sharon M | other | 5,903 |
| May 29, 26 | Hudson Martin Peter | other | 5,903 |
| May 29, 26 | Cross Susan Lee | other | 5,903 |
| May 29, 26 | Purtill Sabra R. | other | 5,903 |
| May 11, 26 | Egan Scott | other | 16,582 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our SPNT coverage
Recent articles, reports, and earnings notes.
No research on SPNT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPNT report →MetLife (NYSE:MET) & SiriusPoint (NYSE:SPNT) Critical Analysis
defenseworld.net · Nov 12
SiriusPoint Q3 Earnings Call Highlights
marketbeat.com · Nov 8
SiriusPoint Ltd. (SPNT) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 6
SiriusPoint (SPNT) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com · Nov 5
SiriusPoint (SPNT) Surpasses Q3 Earnings and Revenue Estimates
zacks.com · Nov 5
SiriusPoint Reports Third Quarter 2026 Results and Announces LPT on Remaining Run-Off Reserves
globenewswire.com · Nov 5
SiriusPoint Appoints John Sauerland to Board of Directors
globenewswire.com · Nov 3
SiriusPoint Announces Date for Third Quarter 2026 Earnings Release
globenewswire.com · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.